Weekly Policy Update: Continuing the Transparency Advocacy and a Business Guide for the Governor

CBSA Continues to Advocate in Opposition to House Bill 1260, Prescription Drug Price Transparency As reported last week, House Bill 1260, Prescription Drug Price Transparency passed on a party line vo...

Learn More

Weekly Policy Update: Prescription Drug Price Transparency

Transparency at the Colorado State Capitol This week CBSA testified in opposition to House Bill 1260, Prescription Drug Price Transparency. The bill was heard in the House Health, Insurance and Enviro...

Learn More

Weekly Policy Update: House Bill 1260 Prescription Drug Transparency, plus the Advamed Fly-In in Washington, D.C.

Urge a NO Vote on HB 1260, Prescription Drug Price Transparency This week CBSA opposed a new bill introduced by the Colorado House that could adversely impact the Colorado bioscience industry, Ho...

Learn More

Weekly Policy Update: Positions on three bills, true transparency, and a visit to D.C.

UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week and we continue to evaluate and make recommendations on legislation being introduced. Outlined below a...

Learn More

Weekly Policy Update: True Transparency and Medicare Stakeholder Input

CBSA promotes the interests of more than 725 bioscience companies and their 30,000 employees. We work every day to create an innovation-friendly business environment ensuring that as an industry we de...

Learn More

Weekly Policy Update: Colorado BioScience Association Highlights State's Life-Saving Medical Breakthroughs for Lawmakers

This week we had a successful CBSA Day at the Capitol. At the event we heard from Lieutenant Governor Donna Lynne on her top priorities, outlook on the opioid and substance abuse task force and the fu...

Learn More

Friday Policy Updates 2/2/2018

As things continue to be active and heat up over at the Colorado State Capitol, this week the Colorado BioScience Association took formal positions on three bills, while continuing to evaluate and mak...

Learn More

Friday Policy Updates 1/26/2018

UNDER THE DOME The CBSA team will be busy this legislative session working on bills that stand to have a negative impact on our industry, with an anticipated 7 healthcare transparency bills aimed at l...

Learn More

Colorado BioScience Association Applauds Suspension of the Medical Device Tax and Reauthorization of CHIP

  Congress delays medical device tax for two years Last night, the President signed a continuing resolution (CR) package, which includes a two-year suspension of the device tax retroactive to Dec...

Learn More

Friday Policy Update 1/19/2018

Another week goes by and we continue to strongly advocate for the repeal of the medical device excise tax. This week in DC, the House passed the continuing resolution (CR) to fund the government until...

Learn More